Top federal drug officials are again making clear that the Schedule I status of substances like marijuana and certain psychedelics is inhibiting valuable research into their therapeutic potential. Over the course of a two-day event last week organized by the National Academies of Sciences, Engineering and Medicine that focused on psychedelics treatment, two key officials … Continue reading Government Policy Makes Psychedelics Research ‘Extremely Hard,’ Top Federal Drug Official Says